MedPath

Effect of Social Media Support and Financial Incentives on PrEP Adherence

Not Applicable
Completed
Conditions
Pre-Exposure Prophylaxis
Interventions
Behavioral: Social Media Group
Behavioral: Financial Incentive
Registration Number
NCT03078153
Lead Sponsor
George Washington University
Brief Summary

The purpose of this study is to determine if social media support and financial incentives improve adherence to Truvada as PrEP in African American, Latino and Asian MSM aged 18 to 24 living in the Washington, DC area who are at high risk for HIV acquisition.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
57
Inclusion Criteria
  • Male assigned at birth (regardless of current gender identity)
  • Age 18-24
  • Black/African American, Latino or Asian
  • HIV negative
  • History of unprotected anal sex with a man in the last 6 months
  • Living within the DC metropolitan statistical area and anticipate remaining within the DC area for the next 6 months
  • Not enrolled in any other HIV prevention trial
  • Interested in taking PrEP
  • Not a current PrEP user and have not taken PrEP in the last 30 days
  • Able to provide informed consent
Exclusion Criteria
  • Female sex at birth
  • Age younger than 18 or older than 24
  • Caucasian
  • HIV positive
  • Actively taking PrEP or having taken PrEP within 30 days of enrollment
  • Chronic hepatitis B infection
  • Known renal insufficiency
  • On probation or parole
  • Any other conditions that the Principal Investigator may consider a contraindication to enrolling in the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Social Media GroupSocial Media GroupProvided social media support through a facebook group for 6 months
Financial IncentiveFinancial IncentiveProvided financial incentive at 3-month and 6-month follow-up visits
Primary Outcome Measures
NameTimeMethod
Adherence To Truvada6 months

Level of Truvada drug levels inside red blood cells (performed by dried blood spots)

Secondary Outcome Measures
NameTimeMethod
New Cases of HIV6 months

Number of reactive HIV rapid and 4th generation tests

Incidence of STIs6 months

Positive RPR, oropharyngeal/rectal/penile chlamydia and gonorrhea during study

Trial Locations

Locations (1)

The GW Medical Faculty Associates

🇺🇸

Washington, District of Columbia, United States

© Copyright 2025. All Rights Reserved by MedPath